Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presenter: Mateusz Tajstra

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Presentation EuroPCR 2024

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Presenter: Bernardo Cortese

May 14, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

Presentation EuroPCR 2024

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

Presenter: Mohamed El Farissi

May 14, 2024

Presentation EuroPCR 2024

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Presenter: Simon Eccleshall

May 14, 2024

Advertisement

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content